PhRMA names new leadership

New leaders include Pfizer's Ian Read, Merck's Kenneth Frazier and Biogen Idec's George Scangos.

April 14, 2014

4:21 pm

Interest group PhRMA announced Friday that Pfizer’s CEO and President Ian Read is its new chair, replacing Celgene CEO Robert Hugin. The Pharmaceutical Research and Manufacturers of America made the announcement at its annual meeting.

Friday’s news included naming Merck President and CEO Kenneth C. Frazier chairman elect of the PhRMA Board of Directors.

Biogen Idec’s CEO George A. Scangos was named treasurer.

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.